Managing dry eye for the busy practitioner
Dry eye disease (DED) is multifactorial disease and is a common complaint experienced by millions of people throughout the world. In 2017, the publication of the TFOS DEWS II report provided a staged management approach to help clinicians treat dry eye disease depending on severity.
This article discusses the different tools available for management of DED, including the use of artificial tears, methods to ensure eyelid hygiene, and supplementation with omega-3 fatty acids. It also looks at how other treatment modalities can be incorporated into our daily practice.
This content is worth 1 CPD point and you can undertake and optional discussion to make this CPD interactive.
CPD Points: 1
CPDpoints.com credits: 1
Expiry Date: 31/12/2024
Interactive points available
Also accepted by
This article provides an overview of ocular emergencies and their key clinical features.
The Lowdown on Demodex
Demodex is one of the most common, but often overlooked, causes of blepharitis and ocular surface inflammation, being associated with between 29% and 74% of all cases of blepharitis. This article will review demodex, its prevalence, its diagnosis and its treatment.